Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic modification of hypertension by sGCα1.

Trends in cardiovascular medicine - 1 Nov 2013

Sips Patrick Y, Buys Emmanuel S

Abstract excerpt

Hypertension is an important modifiable risk factor for coronary heart disease, congestive heart failure, stroke, end-stage renal disease, and peripheral vascular disease, but many of the molecular mechanisms and genetic factors underlying the development of the most common forms of human hypertension remain to be defined. Abundant evidence suggests that nitric oxide (NO) and one of its primary targets, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Pressure
Share to Genome-Wide Association Study
Share to Guanylate Cyclase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypertension

Share to Models, Animal

Share to Models, Cardiovascular

Share to Nitric Oxide

Share to Receptors, Cytoplasmic and Nuclear

Source

Open in PubMed Open full text

Identifiers

PMID: 23755896
DOI: 10.1016/j.tcm.2013.05.001
PMCID: PMC4932824

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic modification of hypertension by sGCα1.PMID 23755896Read ↗

Genetic modifiers of hypertension in soluble guanylate cyclase α1–deficient miceSemantic proximity Read ↗

Androgen-sensitive hypertension associated with soluble guanylate cyclase-α<sub>1</sub> deficiency is mediated by 20-HETESemantic proximity Read ↗

Role of sGC-dependent NO signalling and myocardial infarction risk.Semantic proximity Read ↗

cGMP Signaling in Cardiovascular Diseases: Linking Genotype and Phenotype.Semantic proximity Read ↗

Genetic alterations in the NO-cGMP pathway and cardiovascular risk.Semantic proximity Read ↗

RGS proteins: identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function.Semantic proximity Read ↗

The adducin saga: pleiotropic genomic targets for precision medicine in human hypertension-vascular, renal, and cognitive diseases.Semantic proximity Read ↗

Endothelial SIRT1 prevents age-induced impairment of vasodilator responses by enhancing the expression and activity of soluble guanylyl cyclase in smooth muscle cells.Semantic proximity Read ↗

Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.Semantic proximity Read ↗

[Genetically engineered mice for study of human hypertension].Semantic proximity Read ↗

Functional Characterization of the GUCY1A3 Coronary Artery Disease Risk Locus.Semantic proximity Read ↗

Proatherosclerotic Effect of the α1-Subunit of Soluble Guanylyl Cyclase by Promoting Smooth Muscle Phenotypic Switching.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.